21 May 2013
Keywords: Roche, mtm laboratories, In vitro diagnostics, Cervical cancer, M&A
Article | 19 July 2011
Switzerland’s Roche (ROG: SIX), a global leader in cancer therapeutics and diagnostics, it has signed an ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.